| Balance Sheets | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
|---|---|---|---|---|
| Cash and cash equivalents | 4,939,600 | 4,972,200 | 4,674,700 | 5,239,200 |
| Marketable securities | 1,347,400 | 1,410,600 | 1,526,500 | 1,285,300 |
| Accounts receivable, net | 1,946,400 | 1,893,500 | 1,805,100 | 1,750,600 |
| Inventories | 1,626,800 | 1,499,300 | 1,359,700 | 1,079,800 |
| Prepaid expenses and other current assets | 709,400 | 652,300 | 642,800 | 449,200 |
| Total current assets | 10,569,600 | 10,427,900 | 10,008,800 | 9,804,100 |
| Property and equipment, net | 1,425,100 | 1,335,100 | 1,295,900 | 1,117,800 |
| Goodwill | 1,088,000 | 1,088,000 | 1,088,000 | 1,088,000 |
| Other intangible assets, net | 429,800 | 435,500 | 441,200 | 831,600 |
| Deferred tax assets | 2,937,200 | 2,711,700 | 2,544,300 | 2,308,900 |
| Operating lease assets | 1,591,800 | 1,313,800 | 1,338,500 | 1,396,100 |
| Long-term marketable securities | 5,722,800 | 5,645,900 | 5,156,500 | 4,703,500 |
| Other assets | 1,098,000 | 1,078,800 | 1,007,300 | 990,200 |
| Total assets | 24,862,300 | 24,036,700 | 22,880,500 | 22,240,200 |
| Accounts payable | 420,300 | 442,300 | 445,000 | 395,800 |
| Accrued expenses | 3,613,500 | 3,270,700 | 2,951,800 | 3,219,700 |
| Other current liabilities | 441,500 | 425,400 | 386,400 | 357,600 |
| Total current liabilities | 4,475,300 | 4,138,400 | 3,783,200 | 3,973,100 |
| Long-term operating lease liabilities | 1,834,800 | 1,527,400 | 1,537,700 | 1,588,900 |
| Long-term finance lease liabilities | - | - | 111,400 | 114,000 |
| Other long-term liabilities | 1,233,400 | 1,195,500 | 951,900 | 933,300 |
| Total liabilities | 7,543,500 | 6,861,300 | 6,384,200 | 6,609,300 |
| Common stock, 0.01 par value 500,000,000 shares authorized, 253,951,475 and 256,940,382 shares issued and outstanding, respectively | 2,500 | 2,600 | 2,600 | 2,600 |
| Additional paid-in capital | 5,011,900 | 5,987,900 | 6,172,500 | 6,905,700 |
| Accumulated other comprehensive (loss) income | -64,500 | -101,100 | 68,100 | 28,800 |
| Retained earnings | 12,368,900 | 11,286,000 | 10,253,100 | 8,693,800 |
| Total shareholders equity | 17,318,800 | 17,175,400 | 16,496,300 | 15,630,900 |
| Total liabilities and shareholders equity | 24,862,300 | 24,036,700 | 22,880,500 | 22,240,200 |
VERTEX PHARMACEUTICALS INC MA (VRTX)
VERTEX PHARMACEUTICALS INC MA (VRTX)